{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:24:41Z","timestamp":1765959881625},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1097\/md.0000000000007578","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T14:15:03Z","timestamp":1500473703000},"page":"e7578","source":"Crossref","is-referenced-by-count":21,"title":["Thrombosis and antiphospholipid antibody syndrome during acute Q fever"],"prefix":"10.1097","volume":"96","author":[{"given":"Matthieu","family":"Million","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Bessis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Nouiakh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlaine","family":"Douliery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Edouard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Angelakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Bosseray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Epaulard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Branger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Chaudier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karine","family":"Blanc-Laserre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Ferreira-Maldent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Demonchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Roblot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Djossou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Protopopescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Camoin-Jau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Mege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Raoult","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-59-20210226","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/CMR.00045-16","article-title":"From Q fever to C burnetii infection: a paradigm change","volume":"30","author":"Eldin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"R2-59-20210226","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cid\/civ956","article-title":"Antiphospholipid antibody syndrome with valvular vegetations in acute Q fever","volume":"62","author":"Million","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R3-59-20210226","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/clinids\/18.2.213","article-title":"Prevalence, significance, and specificity of antibodies to phospholipids in Q fever","volume":"18","author":"Ordi-Ros","year":"1994","journal-title":"Clin Infect Dis"},{"key":"R4-59-20210226","first-page":"2335","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Million","year":"2013","journal-title":"N Engl J Med"},{"key":"R5-59-20210226","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/cit191","article-title":"Immunoglobulin G anticardiolipin antibodies and progression to Q fever endocarditis","volume":"57","author":"Million","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R6-59-20210226","doi-asserted-by":"crossref","first-page":"A299","DOI":"10.1016\/j.autrev.2009.11.013","article-title":"The geoepidemiology of the antiphospholipid antibody syndrome","volume":"9","author":"Biggioggero","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R7-59-20210226","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.62.5.388","article-title":"Antiphospholipid antibodies and infections","volume":"62","author":"Asherson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R8-59-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R9-59-20210226","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-2143(97)90004-4","article-title":"Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies","volume":"129","author":"Sanmarco","year":"1997","journal-title":"J Lab Clin Med"},{"key":"R10-59-20210226","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1191\/0961203306lu2258cr","article-title":"Mycoplasma pneumonia with antiphospholipid antibodies and a cardiac thrombus","volume":"15","author":"Bakshi","year":"2006","journal-title":"Lupus"},{"key":"R11-59-20210226","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ppul.20739","article-title":"Mycoplasma pneumonia and pulmonary embolism in a child due to acquired prothrombotic factors","volume":"43","author":"Brown","year":"2008","journal-title":"Pediatr Pulmonol"},{"key":"R12-59-20210226","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0027-9684(15)31045-2","article-title":"Venous thrombosis and pulmonary embolism in a child with pneumonia due to Mycoplasma pneumoniae","volume":"101","author":"Graw-Panzer","year":"2009","journal-title":"J Natl Med Assoc"},{"key":"R13-59-20210226","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1510\/icvts.2010.242115","article-title":"Cardiac thrombus associated with Mycoplasma pneumoniae infection","volume":"11","author":"Nagashima","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R14-59-20210226","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000441-200306000-00008","article-title":"Thrombosis and infection: a case of transient anti-cardiolipin antibody associated with pylephlebitis","volume":"325","author":"Liappis","year":"2003","journal-title":"Am J Med Sci"},{"key":"R15-59-20210226","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcv.2004.07.013","article-title":"Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection","volume":"32","author":"van Hal","year":"2005","journal-title":"J Clin Virol"},{"key":"R16-59-20210226","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/clinids\/24.2.197","article-title":"Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review","volume":"24","author":"Labarca","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R17-59-20210226","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.jinf.2006.03.031","article-title":"Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies","volume":"54","author":"Delbos","year":"2007","journal-title":"J Infect"},{"key":"R18-59-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<137::AID-AJH13>3.0.CO;2-S","article-title":"Acute brachial artery thrombosis as the initial manifestation of human immunodeficiency virus infection","volume":"64","author":"Witz","year":"2000","journal-title":"Am J Hematol"},{"key":"R19-59-20210226","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1191\/096120301669209574","article-title":"Antiphospholipid syndrome induced by HIV","volume":"10","author":"Leder","year":"2001","journal-title":"Lupus"},{"key":"R20-59-20210226","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.meg.0000059140.68845.74","article-title":"Anticardiolipin antibodies in chronic hepatitis B and chronic hepatitis D infection, and hepatitis B-related hepatocellular carcinoma. Relationship with portal vein thrombosis","volume":"15","author":"Elefsiniotis","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R21-59-20210226","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.510230201","article-title":"Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome","volume":"23","author":"Prieto","year":"1996","journal-title":"Hepatology"},{"key":"R22-59-20210226","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N Engl J Med"},{"key":"R23-59-20210226","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/sim.1032","article-title":"Estimating risk and rate levels, ratios and differences in case-control studies","volume":"21","author":"King","year":"2002","journal-title":"Stat Med"},{"key":"R24-59-20210226","first-page":"246","article-title":"ReLogit: rare events logistic regression","volume":"8","author":"Tomz","year":"2003","journal-title":"J Stat Softw"},{"key":"R25-59-20210226","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"R26-59-20210226","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R27-59-20210226","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/INF.0b013e3182843d7e","article-title":"Q Fever with transient antiphospholipid antibodies associated with cholecystitis and splenic infarction","volume":"32","author":"Newcombe","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R28-59-20210226","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.idcr.2014.07.004","article-title":"Large vessel vasculitis in a patient with acute Q-fever: a case report","volume":"1","author":"Baziaka","year":"2014","journal-title":"IDCases"},{"key":"R29-59-20210226","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/cid\/cit419","article-title":"Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment","volume":"57","author":"Million","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R30-59-20210226","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1473-3099(10)70135-3","article-title":"Long-term outcome of Q fever endocarditis: a 26-year personal survey","volume":"10","author":"Million","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R31-59-20210226","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"R32-59-20210226","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0037-1613033","article-title":"Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies","volume":"87","author":"Espinola","year":"2002","journal-title":"Thromb Haemost"},{"key":"R33-59-20210226","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"Edwards","year":"1997","journal-title":"Circulation"},{"key":"R34-59-20210226","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.autrev.2014.12.006","article-title":"Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome","volume":"14","author":"Belizna","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R35-59-20210226","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/jth.12363","article-title":"Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients","volume":"11","author":"Schmidt-Tanguy","year":"2013","journal-title":"J Thromb Haemost"},{"key":"R36-59-20210226","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3899\/jrheum.120157","article-title":"Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and\/or lupus anticoagulant in systemic lupus erythematosus","volume":"40","author":"Broder","year":"2013","journal-title":"J Rheumatol"},{"key":"R37-59-20210226","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12026-016-8812-z","article-title":"Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome","volume":"65","author":"Nuri","year":"202017","journal-title":"Immunol Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:55:29Z","timestamp":1620960929000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201707210-00059"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":37,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007578","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}